FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Dr. Reddy's Laboratories Ranitidine Hydrochloride Tablets Recall

Ranitidine Hydrochloride Tablets, USP, 150 mg, OTC, a) Equate brand Maximum Strength Ac…

Dr. Reddy's Laboratories, Inc. · Bridgewater, NJ

Risk level
Class II
Reported by FDA
Aug 21, 2013
Recall ID
D-884-2013
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Ranitidine Hydrochloride Tablets starting Aug 2, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-884-2013 on Aug 21, 2013. Reason: Microbial Contamination of Non-Sterile Products: A lot of raw material used in the manufacture of Ranitidine was positive for Pseudomonas sp. Status: Terminated.

Why it was recalled

Microbial Contamination of Non-Sterile Products: A lot of raw material used in the manufacture of Ranitidine was positive for Pseudomonas sp.

Product description

Ranitidine Hydrochloride Tablets, USP, 150 mg, OTC, a) Equate brand Maximum Strength Acid Reducer, 65 count bottle Dist. By: Wal-Mart Stores, Inc., Bentonville, AR 72710, NDC 49035-404-61 b)Equaline brand maximum strength heartburn relief, , DISTRIBUTED BY SUPERVALU INC., EDEN PRAIRIE, MN 55344, NDC 41163-404-61, c)Wal-Zan brand 150, MAXIMUM STRENGTH, 24 count bottlle, DISTRIBUTED BY: WALGREEN CO., 200 WILMOT RD., DEERFIELD, IL 63015, NDC 0363-0404-34

Lot numbers, UPCs & expiration codes

a)Lot: 5055822, exp. 03/13; 5056317, exp. 03/15; and 5056507, exp. 04/15 b)Lot: 7956571C, exp. 04/15 c)Lot: 7956572A, exp. 04/15

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-884-2013
Classification
Class II
Status
Terminated
Recall initiated
Aug 2, 2013
FDA report date
Aug 21, 2013
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-884-2013, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
65885
Address
200 Somerset Corporate Blvd Fl 7th
Code information
a)Lot: 5055822, exp. 03/13; 5056317, exp. 03/15; and 5056507, exp. 04/15 b)Lot: 7956571C, exp. 04/15 c)Lot: 7956572A, exp. 04/15
Postal code
08807-2862
Report date
Aug 21, 2013
Product type
Drugs
Recall number
D-884-2013
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Termination date
Mar 19, 2014
Reason for recall
Microbial Contamination of Non-Sterile Products: A lot of raw material used in the manufacture of Ranitidine was positive for Pseudomonas sp.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ranitidine Hydrochloride Tablets, USP, 150 mg, OTC, a) Equate brand Maximum Strength Acid Reducer, 65 count bottle Dist. By: Wal-Mart Stores, Inc., Bentonville, AR 72710, NDC 49035-404-61 b)Equaline brand maximum strength heartburn relief, , DISTRIBUTED BY SUPERVALU INC., EDEN PRAIRIE, MN 55344, NDC 41163-404-61, c)Wal-Zan brand 150, MAXIMUM STRENGTH, 24 count bottlle, DISTRIBUTED BY: WALGREEN CO., 200 WILMOT RD., DEERFIELD, IL 63015, NDC 0363-0404-34
Distribution pattern
Nationwide
Recall initiation date
Aug 2, 2013
Initial firm notification
Letter
Center classification date
Aug 12, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-884-2013, published Aug 21, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls